• Al-Taie, O.H., Mark, H., Gassel, A.M., Wihelm, M., Weissbrich, B. & Scheurlen, M. (1999) Prevention of hepatitis B flare-up during chemotherapy using Lamivudine: case report and review of the literature. Annals of Haematology, 78, 247249.
  • Clark, F.L., Drummond, M.W., Chambers, S., Chapman, B.A. & Patton, W.N. (1998) Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma. Annals of Oncology, 9, 385387.DOI: 10.1023/A:1008206519571
  • Harris, D.S., Jaffe, E.S., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., DeWolf-Peeters, C., Falini, B. & Gatter, K.C. (1994) A revised European-American classification of malignant lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 13611392.
  • Kumagai, K., Takagi, T., Nakamura, S., Sawada, U., Kura, Y., Kodama, F., Shimano, S., Judoh, I., Nakamura, H., Sawada, K. & Ohnoshi, T. (1997) Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan. Annals of Oncology, 8, S107S109.
  • Lai, C.L., Chien, R.N., Leung, N.W., Chang, T.T., Guan, R., Tai, D.I., Ng, K.Y., Wu, P.C., Dent, J.C., Barber, J., Stephenson, S.L. & Gray, D.F. (1998) A one-year trial of lamivudine for chronic hepatitis B. New England Journal of Medicine, 339, 6168.
  • Lau, J.Y., Lai, C.L., Lin, H.J., Lok, A.S., Liang, R.H., Wu, P.C., Chan, T.K. & Todd, D. (1989) Fetal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Quarterly Journal of Medicine, 73, 911917.
  • Liang, R.H., Lok, A.S., Lai, C.L., Chan, T.K., Todd, D. & Chiu, E.K. (1990) Hepatitis B infection in patients with lymphomas. Hematology and Oncology, 8, 261270.
  • Lok, A.S., Liang, R.H., Chiu, E.K., Wong, K.L., Chan, T.K. & Todd, D. (1991) Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology, 100, 182188.
  • Santantonio, T., Mazzola, M., Iacovazzi, T., Miglietta, A., Guastadisegni, A. & Pastore, G. (2000) Long-term follow-up of patientswith anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine. Journal of Hepatology, 32, 300306.DOI: 10.1016/S0168-8278(00)80076-8
  • Silvestri, F., Ermacora, A., Sperotto, A., Patriarca, F., Zaja, F., Damiani, D., Fanin, R. & Baccarani, M. (2000) Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitisB reactivation. British Journal of Haematology, 108, 394396.DOI: 10.1046/j.1365-2141.2000.01847.x
  • Tong, M.J., Sun, S.C., Schaeffer, B.T., Chang, N.K., Lo, K.J. & Peters, R.L. (1971) Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Annals of Internal Medicine, 75, 687691.
  • Yeo, W., Steinberg, J.L., Tam, J.S., Chan, P.K., Leung, N.W., Lam, K.C., Mok, T.S. & Johnson, P.J. (1999) Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy. Journal of Medical Virology, 59, 263239.DOI: 10.1002/(SICI)1096-9071(199911)59:3<263::AID-JMV1>3.3.CO;2-O